The results of the Phase III trials were announced overnight in New York by international pharmaceutical company Merck & Co. who are developing the product.
It was the pioneering research work of Professor Ian Frazer from UQ's Centre for Immunology and Cancer Research (CICR) that led to the development of the vaccine.
Professor Frazer said he was delighted by the news and pleased to have been involved in the vaccine's creation.
"It is very rare, almost unheard of, to achieve a 100% efficacy rate in any treatment, so these results are truly wonderful," he said.
"It is the first time in the world that a vaccine designed to prevent cancer has been developed, and it has happened right here in Australia.
"It is very encouraging to see such great results coming out of Australian research, and developed in conjunction with Australian company CSL, and international pharmaceutical company Merck & Co.
"It is sad that Dr Jian Zhou, who was my research partner, passed away before the work was publicly recognised."
The vaccine is called Gardasil
If the drug is approved by the FDA as anticipated by the international scientific community, the vaccine should be commercially available in early 2006.
The trial is part of the ongoing phase III program for Gardasil
Women aged 16 years to 26 years were chosen at random to receive a three-dose regimen of either Gardasil
Contact: Anton Sanker
Related medicine news :
1. Cervical cancer screening failure linked to poverty
2. Cervical cancer screening programs for low-resource areas appear effective and safe
3. Cervical cancer has profound psychosocial impact on affected women, as well as male partners
4. Conventional prognostic factors fail to explain better prostate cancer survival in most Asian men
5. Survival differences by race most apparent in advanced stages of breast cancer
6. Stomach cancer rate set to fall further 25 percent over next decade
7. MRI finds breast cancer before it becomes dangerous
8. Investigators uncover intriguing clues to why persistent acid reflux sometimes turns into cancer
9. New cause of tamoxifen resistance in breast cancer cells discovered at Lombardi
10. Pathway links inflammation, angiogenesis and breast cancer
11. Using MRI for diagnosis could help prevent breast cancer progression